OMT for Sleep Quality in Parkinson's Disease
Official title: Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
Run by New York Institute of Technology · NCT06671600 · Data updated 2026-11-12
This study tests whether osteopathic manipulative treatment (OMT) can improve sleep quality in people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | New York Institute of Technology Academic / other |
| Locations | 1 site (Old Westbury, New York) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT06671600 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Parkinson's disease (Hoehn and Yahr 0-3) who have sleep disturbances and can tolerate OMM sessions.
✕Probably not a fit
Participants with more advanced PD (Hoehn and Yahr 4-5) or those with other sleep disorders or medications affecting sleep may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this interventional study, adults with Parkinson's disease and sleep disturbances are assigned to receive either osteopathic manipulative treatment or a sham, light-touch control. The researchers will measure changes in sleep quality, cognitive function, and daily activities using sleep surveys and wearable monitoring. The approach targets specific regions (cranial, cervical, thoracic) to enhance relaxation and circulation, with sessions conducted in a setting suitable for PD patients. The study compares OMT to a sham control to determine if the hands-on therapy provides sleep-related benefits beyond placebo.
Why it matters
Potential benefit: If successful, patients may experience better sleep, which could improve daytime functioning and quality of life.
How similar studies have gone: Previous research suggests sleep improvements with OMT, but specific PD-focused evidence is limited and this study builds on that groundwork.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must have a diagnosis of Parkinson's disease as per a neurologist * Severity of 0-3 on the Hoehn and Yahr (H-Y) Scale * Able to receive OMM * Able to be in a supine and prone position. * Able to wear a Fitbit watch and an oxygen saturation ring for the duration of the study (including when sleeping). * Have sleep disturbance complaints. Exclusion Criteria: * Patients on medications that affect sleep * Have a pre-existing sleep disorder diagnosis * Those who have a concurrent neurological diagnosis that would confound sleep patterns (ie. narcolepsy) * Contraindications to the OMM techniques used in this protocol * Severity of 4 and 5 on the Hoehn and Yahr Scale
Where it's running
-
New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center
Old Westbury, New York, United States Recruiting
Study contacts
- Study coordinator: Sheldon Yao, Doctor of Osteopathic Medicine
- Email: sheldon.yao@nyit.edu
- Phone: 516-686-3799
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Mental imagery with self-regulation to help daily activities in Parkinson's disease
This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.
-
Real-world experiences of Inbrija for Parkinson's OFF episodes
This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Test of RO7568282 in early Parkinson's disease
This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.